Arash Karimi
Impact in
- Molecular Medicine top 5%
- Curcumin's Biomedical Applications
- Biochemistry top 10%
- Phytochemicals and Antioxidant Activities
Papers in
-
- Curcumin's Biomedical Applications 8
-
- Natural Antidiabetic Agents Studies 6
- Co-authors
- Mahdi Vajdi (21 shared papers)Hamid Reza Niazkar (9 shared papers)Helda Tutunchi (8 shared papers)Ali Tarighat‐Esfanjani (6 shared papers)Hamed Shoorei (5 shared papers)Arezoo Moini Jazani (7 shared papers)Fatemeh Naeini (4 shared papers)Vali Musazadeh (6 shared papers)
- Journals
- Clinical and Experimental Pharmacology and Physiology (3 papers)International Journal of Clinical Practice (3 papers)Diabetes & Metabolic Syndrome Clinical Research & Reviews (2 papers)Phytotherapy Research (2 papers)BMC Endocrine Disorders (2 papers)
- Partner nations
- IranUnited StatesCanada
In The Last Decade
Arash Karimi
39 papers receiving 596 citations
Peers
Comparison fields: 5 of 91
- Molecular Medicine 113
- Biochemistry 49
- Pharmacology 67
- Complementary and alternative medicine 52
- Endocrinology, Diabetes and Metabolism 88
Countries citing papers authored by Arash Karimi
This map shows the geographic impact of Arash Karimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arash Karimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arash Karimi more than expected).
Fields of papers citing papers by Arash Karimi
This network shows the impact of papers produced by Arash Karimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arash Karimi. The network helps show where Arash Karimi may publish in the future.
Co-authors
The 25 scholars most cited alongside Arash Karimi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 69 | |
| 2 | 2021 | 45 | |
| 3 | 2019 | 43 | |
| 4 | 2022 | 41 | |
| 5 | 2020 | 30 | |
| 6 | 2023 | 26 | |
| 7 | 2022 | 26 | |
| 8 | 2023 | 26 | |
| 9 | 2021 | 25 | |
| 10 | 2023 | 21 | |
| 11 | 2023 | 20 | |
| 12 | 2022 | 18 | |
| 13 | 2022 | 17 | |
| 14 | 2020 | 16 | |
| 15 | 2023 | 14 | |
| 16 | 2022 | 14 | |
| 17 | 2021 | 14 | |
| 18 | 2022 | 13 | |
| 19 | 2021 | 13 | |
| 20 | 2022 | 12 |
About Arash Karimi
Arash Karimi is a scholar working on Molecular Medicine, Endocrinology, Diabetes and Metabolism, Epidemiology, Molecular Biology and Immunology, having authored 40 papers that have together received 611 indexed citations. Recurring topics across this work include Curcumin's Biomedical Applications (8 papers), Natural Antidiabetic Agents Studies (6 papers), Vitamin C and Antioxidants Research (5 papers), Inflammation biomarkers and pathways (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Medicinal Plants and Bioactive Compounds (3 papers), Chromium effects and bioremediation (3 papers) and Obesity, Physical Activity, Diet (3 papers). The work is most often cited by research in Molecular Medicine (113 citations), Biochemistry (49 citations), Pharmacology (67 citations), Complementary and alternative medicine (52 citations) and Endocrinology, Diabetes and Metabolism (88 citations). Arash Karimi has collaborated with scholars based in Iran, United States and Canada. Frequent co-authors include Mahdi Vajdi, Hamid Reza Niazkar, Helda Tutunchi, Ali Tarighat‐Esfanjani, Hamed Shoorei, Arezoo Moini Jazani, Fatemeh Naeini, Vali Musazadeh, Ata Mahmoodpoor and Vahid Asghariazar. Their work appears in journals such as Clinical and Experimental Pharmacology and Physiology, International Journal of Clinical Practice, Diabetes & Metabolic Syndrome Clinical Research & Reviews, Phytotherapy Research and BMC Endocrine Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.